While searching for solutions to heart problems I noticed that many of the same solutions also help with other common health problems like cancer.
For those who are healthy don't wait for problems to appear. An ounce of prevention is better than any cure.
Some of these antioxidant solutions are commonly known.
Vitamin A
Vitamin C
Vitamin E
Vitamin B(B6, B9, B12)
Lesser known but equally important
Alpha Lipoic Acid
Seanol
lycopene
CoQ10
Conjugated linoleic Acid(CLA)
DHEA
Selenium
Modified Citrus Pectin
Some of these items are not available in Singapore. Go look at places like
www.iherb.com
They do have a good range, prices & deliver to Spore. If you use the code "kok015" you'll get a $5 discount
I a strong believer in the importance of detoxifying one's body. When your young, your body might be able to defend itself. However with age, one's polluted body is less able to defend itself.
Currently taking on a regular basis the following product:
http://www.iherb.com/Jarrow-Formulas-Heavy-Metal-Detox-ToxGuard-90-Veggie-Caps/7774?at=0
It's cheaper than the EcoNugenics product that was used in studies.
You've probably never heard of Modified Pectins, at least I didn't. I'm taking a product called Profibe for cholesterol control but surprised that there's a "Modified" form which is a detoxifier. Take note that "Modified" and normal pectin is slightly different . If you are interested to find out more I've included the following article:
New Modified Citrus Pectin Slows Cancer Progression and Stops Cancer Cells in Their...
Tue Jun 3, 2008 11:15am EDT
New Modified Citrus Pectin Slows Cancer Progression and Stops Cancer Cells in Their Tracks
Study Shows New Modified Citrus Pectin Works as Well as Chemo
Without Toxicity and Improves Quality of Life in Advanced Disease
SANTA ROSA, Calif.--(Business Wire)--
Better Health Publishing announced today that many people with
cancer could be helped by a new form of Modified Citrus Pectin (MCP)
that may work as well as chemotherapy in advanced disease stages; yet
without the dangerous toxicity. These published findings of new
capabilities for MCP have the potential to revolutionize integrative
cancer healthcare.
Previous research with MCP has shown it to be effective in slowing
the progression, metastasis and angiogenesis of several types of
cancer. Now with further improvement in the modification process, more
of the effective substance can be utilized by the body. The first
human study described below was done with patients with late stage,
breast, prostate, colorectal, kidney, pleural or lung, cervix/uterine
cancer, liver, pharynx, pancreatic, stomach, melanoma and bile duct
cancers.
This landmark clinical trial was published in the peer-reviewed
journal Clinical Medicine: Oncology, where it showed a significant
improvement of quality of life and stabilization of disease for
patients with advanced solid tumors. The results of the landmark
advanced tumor study clearly demonstrate MCP's enhanced capabilities.
"This is a very important breakthrough destined to help a lot of
people," said Dr. Isaac Eliaz, a prominent doctor of Integrative
Medicine and MCP researcher. "MCP may have the benefits similar to
chemotherapy in advanced cancers, but without the side effects. This
study sheds additional light on the potential benefits of MCP in
cancer prevention and treatment."
A background report on the development of MCP in integrative
cancer healthcare is available through Better Health Publishing at the
following url: www.betterhealthpublishing.org/mcpreport
MCP, a natural substance modified from the peel of citrus fruit
has been used during the past decade in integrative cancer therapy to
help keep aberrant cells from clustering and blocking the formation of
blood vessel attachment. The absorption into the blood stream is based
on the size and weight of its molecules.
MCP molecules bind to receptors on cancerous cells, preventing
these cells from attaching to healthy tissue and blocking the
formation of blood vessels to feed the cancerous cells. Once this has
occurred, the cancer cells starve and die or are eliminated by the
immune system.
In the past, the enzymatic modification process produced too much
total breakdown of the pectin molecules when it tried to achieve the
effective low molecular weight absorbable chains. The new MCP also
goes through an enzymatic process that reduces the pectin's molecular
size and modifies it to better control the amount of total breakdown
of the citrus pectin. These new developments led to an improved MCP,
lower in weight, which allows it to be more systemic, circulating
through the blood stream and allowing the body to absorb more of the
effective molecules.
Treatment and Scientific Data of Study:
The treatment in the advanced tumor and previous studies consisted
of the oral intake of five grams of MCP three times a day. One cycle
of therapy was defined as four weeks of treatment. Objectives were
clinical benefit (pain, functional performance, weight change),
safety, tumor response (RESIST criteria) and quality of life.
The results proved very exciting. Forty-nine patients (between 36
and 82 years old) with various advanced solid tumors were enrolled.
Twenty-nine patients were evaluated for clinical benefit after two
cycles of treatment. All patients tolerated the therapy well without
any adverse effects. The results also demonstrated that after two
cycles of oral intake of MCP, 6/29, (20.7%) had an overall clinical
benefit with a stabilization or improvement of life quality. On intent
to treat basis 11/49 patients (22.5%) showed a stable disease after
two cycles and 12.3% had a SD for more than 24 weeks. One patient with
advanced and hormonal resistant prostate cancer had a 50% decrease in
PSA with significant improvement in his quality of life. Most of the
patients had improvements in their life quality as reflected in the
Karnofsky scores.
The MCP used in the advanced tumor study is now commercially
available in the US. It's called PectaSol-C and distributed by
EcoNugenics, Santa Rosa, CA.
For those who are healthy don't wait for problems to appear. An ounce of prevention is better than any cure.
Some of these antioxidant solutions are commonly known.
Vitamin A
Vitamin C
Vitamin E
Vitamin B(B6, B9, B12)
Lesser known but equally important
Alpha Lipoic Acid
Seanol
lycopene
CoQ10
Conjugated linoleic Acid(CLA)
DHEA
Selenium
Modified Citrus Pectin
Some of these items are not available in Singapore. Go look at places like
www.iherb.com
They do have a good range, prices & deliver to Spore. If you use the code "kok015" you'll get a $5 discount
I a strong believer in the importance of detoxifying one's body. When your young, your body might be able to defend itself. However with age, one's polluted body is less able to defend itself.
Currently taking on a regular basis the following product:
http://www.iherb.com/Jarrow-Formulas-Heavy-Metal-Detox-ToxGuard-90-Veggie-Caps/7774?at=0
It's cheaper than the EcoNugenics product that was used in studies.
You've probably never heard of Modified Pectins, at least I didn't. I'm taking a product called Profibe for cholesterol control but surprised that there's a "Modified" form which is a detoxifier. Take note that "Modified" and normal pectin is slightly different . If you are interested to find out more I've included the following article:
New Modified Citrus Pectin Slows Cancer Progression and Stops Cancer Cells in Their...
Tue Jun 3, 2008 11:15am EDT
New Modified Citrus Pectin Slows Cancer Progression and Stops Cancer Cells in Their Tracks
Study Shows New Modified Citrus Pectin Works as Well as Chemo
Without Toxicity and Improves Quality of Life in Advanced Disease
SANTA ROSA, Calif.--(Business Wire)--
Better Health Publishing announced today that many people with
cancer could be helped by a new form of Modified Citrus Pectin (MCP)
that may work as well as chemotherapy in advanced disease stages; yet
without the dangerous toxicity. These published findings of new
capabilities for MCP have the potential to revolutionize integrative
cancer healthcare.
Previous research with MCP has shown it to be effective in slowing
the progression, metastasis and angiogenesis of several types of
cancer. Now with further improvement in the modification process, more
of the effective substance can be utilized by the body. The first
human study described below was done with patients with late stage,
breast, prostate, colorectal, kidney, pleural or lung, cervix/uterine
cancer, liver, pharynx, pancreatic, stomach, melanoma and bile duct
cancers.
This landmark clinical trial was published in the peer-reviewed
journal Clinical Medicine: Oncology, where it showed a significant
improvement of quality of life and stabilization of disease for
patients with advanced solid tumors. The results of the landmark
advanced tumor study clearly demonstrate MCP's enhanced capabilities.
"This is a very important breakthrough destined to help a lot of
people," said Dr. Isaac Eliaz, a prominent doctor of Integrative
Medicine and MCP researcher. "MCP may have the benefits similar to
chemotherapy in advanced cancers, but without the side effects. This
study sheds additional light on the potential benefits of MCP in
cancer prevention and treatment."
A background report on the development of MCP in integrative
cancer healthcare is available through Better Health Publishing at the
following url: www.betterhealthpublishing.org/mcpreport
MCP, a natural substance modified from the peel of citrus fruit
has been used during the past decade in integrative cancer therapy to
help keep aberrant cells from clustering and blocking the formation of
blood vessel attachment. The absorption into the blood stream is based
on the size and weight of its molecules.
MCP molecules bind to receptors on cancerous cells, preventing
these cells from attaching to healthy tissue and blocking the
formation of blood vessels to feed the cancerous cells. Once this has
occurred, the cancer cells starve and die or are eliminated by the
immune system.
In the past, the enzymatic modification process produced too much
total breakdown of the pectin molecules when it tried to achieve the
effective low molecular weight absorbable chains. The new MCP also
goes through an enzymatic process that reduces the pectin's molecular
size and modifies it to better control the amount of total breakdown
of the citrus pectin. These new developments led to an improved MCP,
lower in weight, which allows it to be more systemic, circulating
through the blood stream and allowing the body to absorb more of the
effective molecules.
Treatment and Scientific Data of Study:
The treatment in the advanced tumor and previous studies consisted
of the oral intake of five grams of MCP three times a day. One cycle
of therapy was defined as four weeks of treatment. Objectives were
clinical benefit (pain, functional performance, weight change),
safety, tumor response (RESIST criteria) and quality of life.
The results proved very exciting. Forty-nine patients (between 36
and 82 years old) with various advanced solid tumors were enrolled.
Twenty-nine patients were evaluated for clinical benefit after two
cycles of treatment. All patients tolerated the therapy well without
any adverse effects. The results also demonstrated that after two
cycles of oral intake of MCP, 6/29, (20.7%) had an overall clinical
benefit with a stabilization or improvement of life quality. On intent
to treat basis 11/49 patients (22.5%) showed a stable disease after
two cycles and 12.3% had a SD for more than 24 weeks. One patient with
advanced and hormonal resistant prostate cancer had a 50% decrease in
PSA with significant improvement in his quality of life. Most of the
patients had improvements in their life quality as reflected in the
Karnofsky scores.
The MCP used in the advanced tumor study is now commercially
available in the US. It's called PectaSol-C and distributed by
EcoNugenics, Santa Rosa, CA.
